Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 12, 2001, Pages 674-679

  Van Burik, Jo Anne H ^a   Lawatsch, Eric J ^a   DeFor, Todd E ^a   Weisdorf, Daniel J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cytomegalovirus; Enteritis; Stem cell transplantation

Indexed keywords

ACICLOVIR; BUSULFAN; CLOTRIMAZOLE; CYCLOPHOSPHAMIDE; FLUCONAZOLE; GANCICLOVIR; IMMUNOGLOBULIN; PLACEBO; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DATA BASE; DRUG MEGADOSE; DRUG RESPONSE; ENTERITIS; FEMALE; FOLLOW UP; GASTROINTESTINAL INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; INCIDENCE; MALE; MYCOSIS; ONSET AGE; PNEUMONIA; PROPHYLAXIS; RECIPIENT; RISK FACTOR; SURVIVAL RATE; UNIVERSITY HOSPITAL; VIREMIA; VIROLOGY; ADOLESCENT; CAUSE OF DEATH; CHILD; CYTOMEGALIC INCLUSION BODY DISEASE; FACTUAL DATABASE; INFANT; MIDDLE AGED; OPPORTUNISTIC INFECTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; DATABASES, FACTUAL; ENTERITIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VIREMIA;

EID: 0035544030     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2001.v7.pm11787530     Document Type: Article

References (23)

1. Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy
2. Cytomegalovirus infection in marrow transplantation
3. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation
4. Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation
5. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant
6. Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: A report from the European Group for Blood and Marrow Transplantation (EMBIT)
7. A comparison of filtered leukocyte-reduced and cytomegalovirus seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant
8. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients: A randomized, placebo-controlled trial
9. Virological clinical, and opthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation
10. CMV enteritis causing segmental ischemia and massive intestinal hemorrhage
11. Isolated cytomegalovirus ileitis detected by colonoscopy
12. Diffuse intestinal ulceration after marrow transplantation: A clinicopathologic study of 13 patients
13. Cytomegalovirus infection causing pseudomenbranous colitis
14. Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: Prevention and therapy
15. Prednisone therapy for acute graft-versus-host disease: Short- versus long-term treatment. A prospective randomized trial
16. Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: Risk factors and clinical outcome
17. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related on unrelated donors
18. CMV antigenemia following bone marrow transplantation: Risk factors and outcomes
19. Non-parametric inference for cumulative incidence functions in competing risks studies
20. Nonparametric estimation from incomplete observations
21. Cytomegalovirus infection after autologous bone marrow transplantation: Comparison to infection after allogeneic bone marrow transplantation
22. Simultaneous occurrence of Clostridium difficile and cytomegalovirus colitis in a recipient of autologous stem cell transplantation